Comments Off on Alumis files for IPO to support work on oral TYK2 blockers
Comments Off on Foresite Labs Welcomes Dr. David Weinreich as Operating Partner
Comments Off on Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D
